The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Calciject PMD Solution for Injection

Norbrook Laboratories (Ireland) LimitedVPA22664/029/001

Main Information

Trade NameCalciject PMD Solution for Injection
Active SubstancesCalcium gluconate
Boric acid
Dextrose Monohydrate
Magnesium hypophosphite hexahydrate
Dosage FormSolution for injection
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/029/001

Group Information

ATC CodeQA12AA20 calcium (different salts in combination)
Therapeutic ClassVitamins and minerals


License statusWithdrawn
Withdrawn Date31/03/2022
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back